Kevin Schuyler, Director at ADIAL PHARMACEUTICALS, INC. (ADIL), bought 700 shares at $2.74 ($2K) on 2023-09-29, disclosed to the SEC on 2023-10-03.
Open-market purchase of $2k ADIL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| FRZA | BUY | 2022-12-22 | $6K | — | Filing → |
| VEEE | BUY | 2022-12-22 | $2K | — | Filing → |
| FRZA | BUY | 2022-12-21 | $5K | — | Filing → |